| Literature DB >> 27544825 |
Chae-Seok Lim1, Hyopil Kim1, Nam-Kyung Yu1, Sukjae Joshua Kang1, TaeHyun Kim1, Hyoung-Gon Ko1, Jaehyun Lee1, Jung-Eun Yang1, Hyun-Hee Ryu2, Taesung Park3, Jungsoo Gim3, Hye Jin Nam4, Sung Hee Baek4, Stephanie Wegener5, Dietmar Schmitz5, Tobias M Boeckers6, Min Goo Lee7, Eunjoon Kim8, Jae-Hyung Lee9, Yong-Seok Lee10, Bong-Kiun Kaang11.
Abstract
Autism spectrum disorders (ASDs) are a group of developmental disorders that cause variable and heterogeneous phenotypes across three behavioral domains such as atypical social behavior, disrupted communications, and highly restricted and repetitive behaviors. In addition to these core symptoms, other neurological abnormalities are associated with ASD, including intellectual disability (ID). However, the molecular etiology underlying these behavioral heterogeneities in ASD is unclear. Mutations in SHANK2 genes are associated with ASD and ID. Interestingly, two lines of Shank2 knockout mice (e6-7 KO and e7 KO) showed shared and distinct phenotypes. Here, we found that the expression levels of Gabra2, as well as of GABA receptor-mediated inhibitory neurotransmission, are reduced in Shank2 e6-7, but not in e7 KO mice compared with their own wild type littermates. Furthermore, treatment of Shank2 e6-7 KO mice with an allosteric modulator for the GABAA receptor reverses spatial memory deficits, indicating that reduced inhibitory neurotransmission may cause memory deficits in Shank2 e6-7 KO mice. This article is part of the Special Issue entitled 'Ionotropic glutamate receptors'.Entities:
Keywords: Autism spectrum disorders; Gabra2; I/E ratio; Shank2; Spatial memory
Mesh:
Substances:
Year: 2016 PMID: 27544825 DOI: 10.1016/j.neuropharm.2016.08.016
Source DB: PubMed Journal: Neuropharmacology ISSN: 0028-3908 Impact factor: 5.250